Psychiatr. pro Praxi, 2005; 5: 237-240

METABOLIC SYNDROME IN PSYCHIATRY

doc. MUDr. Vladimír Pidrman Ph.D1, doc. MUDr. Jiří Horáček CSc2
1 Psychiatrická klinika FN a LF UP, Olomouc
2 II. interní klinika LF UK a Fakultní nemocnice, Hradec Králové

The authors show the risk of obesity as a principal risk of metabolic syndrome explain definition of metabolic syndrome and describe its consequences. They describe risks of metabolic syndrome in psychiatry. They underline connections between metabolic and psychiatry disorders as well as the role of antipsychotic medications in the development of metabolic disorders.

Keywords: Key words: metabolic syndrome, obesity, insulin resistance, antipsychotic medications.

Published: February 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pidrman V, Horáček J. METABOLIC SYNDROME IN PSYCHIATRY. Psychiatr. praxi. 2005;9(5):237-240.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dixon L.Weiden P, Delanthy J, et al. Prevalence and correlates of diabetes in National Schizophrenia Samples. Schizophr Bull 2000; 26: 903-912. Go to original source... Go to PubMed...
    2. Grundy SA. Obezity, Metabolic Syndrome and Cardiovascular Disease. J Clin Endocrinol Metab, June 2004; 89 (6): 2595-2600. Go to original source... Go to PubMed...
    3. Glassman AH. Clinical Management of Cardiovascular Risk During Treatment With Psychotropics Drugs. J Clin Psychiatry, 2002; 63 (suppl 9): 12-17.
    4. Henderson DC. Atypical Antipsychotic-induced diabetes mellitus: how strong is the evidence? CNS Drugs 2002; 16: 77-89. Go to original source... Go to PubMed...
    5. Lebovitz HE. Insulin resistence: definition and consequences. Exp Clin Endocrinol Diabetes 2001, 109 (suppl 2): S 135-S148. Go to original source... Go to PubMed...
    6. Melkersson K, Dahl ML. Adverse Metabolic Effects Associated with Atypicyl Antipsychotics. Drugs, 2004; 64 (7): 701-723. Go to original source... Go to PubMed...
    7. National Heart, Lung and Blood Institute. The Practical Guide: Identification,Evaluation and Treatment of Overweight and Obesity in Adults.Available at: http://www.nhlbi.nih.gov/guidelines/obesity/practgde.pdf.
    8. National Heart, Lung and Blood Institute. Clinical guidelines on the Identification,Evaluation and Treatment of Overweight and Obesity in Adults.Available at: http://www.nhlbi.nih.gov/guidelines/ob_gdlns.pdf.
    9. National Center for Health Statistics. Prevalence and Overweight and Obesity Among Adults, 1999.
    10. Newcomer JW. Metabolic Risk During Antipsychotic Treatment. Clinical Therapeutics, 26: 12, 2004; 1936-1946. Go to original source... Go to PubMed...
    11. Report of Expert Committee on Diagnosis and Classification of Diabetes mellitus. Diabetes Care 2000; 23: S 4-S19.
    12. Stahl SM. The metabolic syndrom. J Clin Psychiatry, 63:12, 2002;1094-1095. Go to original source... Go to PubMed...
    13. Svačina ©. Metabolické účinky psychofarmak. Triton, Praha, 2004: 188 s.
    14. Wirsching DA, Boyd JA,Meng LR,et al. The effects of novel antipsychotics on glucose and lipide levels. J Clin Psychiatry 2002; 63: 856-865. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.